Ionctura
Clinical trials sponsored by Ionctura, explained in plain language.
-
New hope for tough lung cancers: experimental combo targets resistant tumors
Disease control OngoingThis study tests a new drug combination (roginolisib plus dostarlimab, with or without docetaxel) in 45 adults with advanced non-squamous lung cancer that has worsened after standard treatments. The goal is to see if the combination can shrink tumors or slow disease progression b…
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
New pill fights deadly eye cancer in groundbreaking trial
Disease control OngoingThis study is testing whether an experimental oral medication called roginolisib can help people with advanced uveal melanoma (a type of eye cancer) live longer than current standard treatments. About 85 adults who have already tried immunotherapy will receive either roginolisib …
Phase: PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC